Skip to main content
Fig. 4 | Molecular Neurodegeneration

Fig. 4

From: TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation

Fig. 4

Strategies to tackle questions around TREM2/PLCγ2, and identify therapeutics for AD. The combination of efforts from several disciplines (including structural biology, immunology and neurobiology) and the assessment of mouse and human models, together with the generation of new selective pharmacological tools for TREM2/PLCγ2 will help to address these questions

Back to article page